Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125622501 | 12562250 | 1 | I | 20160711 | 20160715 | 20160715 | EXP | PHHY2016NG095601 | NOVARTIS | ILIYASU G, ABDU A, DAYYAB FM, TIAMIYU AB, HABIB ZG, ADAMU B ET AL.. POST-RENAL TRANSPLANT INFECTIONS: SINGLE CENTER EXPERIENCE FROM NIGERIA. TRANSPLANT INFECTIOUS DISEASE. 2016;1-9 | 0.00 | Y | 0.00000 | 20160715 | OT | NG | NG |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125622501 | 12562250 | 1 | PS | CICLOSPORIN | CYCLOSPORINE | 1 | Unknown | U | 50574 | ||||||||||
| 125622501 | 12562250 | 2 | SS | CICLOSPORIN | CYCLOSPORINE | 1 | U | 50574 | |||||||||||
| 125622501 | 12562250 | 3 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | U | 0 | ||||||||||
| 125622501 | 12562250 | 4 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | U | 0 | |||||||||||
| 125622501 | 12562250 | 5 | SS | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Unknown | U | 0 | ||||||||||
| 125622501 | 12562250 | 6 | SS | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | U | 0 | |||||||||||
| 125622501 | 12562250 | 7 | SS | AZATHIOPRINE. | AZATHIOPRINE | 1 | Unknown | U | 0 | ||||||||||
| 125622501 | 12562250 | 8 | SS | AZATHIOPRINE. | AZATHIOPRINE | 1 | U | 0 | |||||||||||
| 125622501 | 12562250 | 9 | C | AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLINCLAVULANATE POTASSIUM | 1 | Intravenous (not otherwise specified) | 1.2 G, Q8H, CONTINUED FOR 7 DAYS POSTOPERATIVELY | U | 0 | 1.2 | G | Q8H | ||||||
| 125622501 | 12562250 | 10 | C | COTRIMOXAZOLE | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Unknown | 160/800 MG, BID, CONTINUED FOR 6 MONTH POST-TRANSPLANT | U | 0 | 1 | DF | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125622501 | 12562250 | 1 | Renal transplant |
| 125622501 | 12562250 | 2 | Immunosuppressant drug therapy |
| 125622501 | 12562250 | 3 | Renal transplant |
| 125622501 | 12562250 | 4 | Immunosuppressant drug therapy |
| 125622501 | 12562250 | 5 | Renal transplant |
| 125622501 | 12562250 | 6 | Immunosuppressant drug therapy |
| 125622501 | 12562250 | 7 | Renal transplant |
| 125622501 | 12562250 | 8 | Immunosuppressant drug therapy |
| 125622501 | 12562250 | 9 | Antibiotic prophylaxis |
| 125622501 | 12562250 | 10 | Antibiotic prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125622501 | 12562250 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125622501 | 12562250 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |